HSBC Holdings’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $39.3M | Buy |
156,895
+10,023
| +7% | +$2.49M | 0.02% | 571 |
|
|
2025
Q4 | $40.4M | Buy |
146,872
+27,745
| +23% | +$7.59M | 0.02% | 548 |
|
|
2025
Q3 | $31.3M | Sell |
119,127
-13,131
| -10% | -$3.19M | 0.02% | 592 |
|
|
2025
Q2 | $28.9M | Sell |
132,258
-5,060
| -4% | -$1.08M | 0.02% | 603 |
|
|
2025
Q1 | $30.7M | Sell |
137,318
-3,458
| -2% | -$953K | 0.02% | 600 |
|
|
2024
Q4 | $46.1M | Sell |
140,776
-3,729
| -3% | -$1.17M | 0.03% | 503 |
|
|
2024
Q3 | $43.5M | Sell |
144,505
-42,213
| -23% | -$12.9M | 0.03% | 517 |
|
|
2024
Q2 | $61.7M | Buy |
186,718
+19,561
| +12% | +$6.91M | 0.04% | 403 |
|
|
2024
Q1 | $66.1M | Buy |
167,157
+28,689
| +21% | +$10.6M | 0.04% | 386 |
|
|
2023
Q4 | $48.7M | Buy |
138,468
+39,392
| +40% | +$13.9M | 0.04% | 423 |
|
|
2023
Q3 | $37.2M | Sell |
99,076
-5,036
| -5% | -$1.95M | 0.04% | 445 |
|
|
2023
Q2 | $39.9M | Sell |
104,112
-18,603
| -15% | -$6.65M | 0.04% | 440 |
|
|
2023
Q1 | $42.5M | Sell |
122,715
-140,000
| -53% | -$40.9M | 0.05% | 388 |
|
|
2022
Q4 | $61.7M | Buy |
262,715
+39,199
| +18% | +$9.29M | 0.07% | 293 |
|
|
2022
Q3 | $55.4M | Buy |
223,516
+29,882
| +15% | +$9.1M | 0.09% | 218 |
|
|
2022
Q2 | $58.5M | Buy |
193,634
+59,712
| +45% | +$19.4M | 0.08% | 224 |
|
|
2022
Q1 | $55.4M | Sell |
133,922
-3,054
| -2% | -$1.2M | 0.07% | 282 |
|
|
2021
Q4 | $64.3M | Buy |
136,976
+15,305
| +13% | +$6.59M | 0.06% | 314 |
|
|
2021
Q3 | $52M | Buy |
121,671
+1,285
| +1% | +$542K | 0.05% | 327 |
|
|
2021
Q2 | $43.3M | Sell |
120,386
-3,530
| -3% | -$1.17M | 0.05% | 374 |
|
|
2021
Q1 | $34.8M | Sell |
123,916
-13,277
| -10% | -$3.8M | 0.04% | 422 |
|
|
2020
Q4 | $38.8M | Buy |
137,193
+13,023
| +10% | +$3.65M | 0.05% | 352 |
|
|
2020
Q3 | $34.2M | Buy |
124,170
+15,348
| +14% | +$4.06M | 0.05% | 313 |
|
|
2020
Q2 | $24.7M | Buy |
108,822
+60,391
| +125% | +$11.9M | 0.05% | 368 |
|
|
2020
Q1 | $7.38M | Buy |
48,431
+30,793
| +175% | +$4.74M | 0.02% | 691 |
|
|
2019
Q4 | $2.67M | Sell |
17,638
-2,500
| -12% | -$364K | ﹤0.01% | 1383 |
|
|
2019
Q3 | $2.86M | Buy |
20,138
+6,323
| +46% | +$871K | 0.01% | 1430 |
|
|
2019
Q2 | $1.73M | Sell |
13,815
-18,049
| -57% | -$2.13M | ﹤0.01% | 1574 |
|
|
2019
Q1 | $3.51M | Buy |
31,864
+24,682
| +344% | +$2.57M | 0.01% | 1259 |
|
|
2018
Q4 | $705K | Sell |
7,182
-3,224
| -31% | -$350K | ﹤0.01% | 1961 |
|
|
2018
Q3 | $1.28M | Buy |
10,406
+867
| +9% | +$97.2K | ﹤0.01% | 1641 |
|
|
2018
Q2 | $948K | Buy |
9,539
+1,229
| +15% | +$113K | ﹤0.01% | 1800 |
|
|
2018
Q1 | $733K | Sell |
8,310
-950
| -10% | -$88.9K | ﹤0.01% | 1773 |
|
|
2017
Q4 | $912K | Buy |
9,260
+711
| +8% | +$69.7K | ﹤0.01% | 1315 |
|
|
2017
Q3 | $822K | Buy |
8,549
+1,106
| +15% | +$100K | ﹤0.01% | 1542 |
|
|
2017
Q2 | $704K | Buy |
7,443
+890
| +14% | +$81.9K | ﹤0.01% | 1566 |
|
|
2017
Q1 | $536K | Buy |
6,553
+154
| +2% | +$12.9K | ﹤0.01% | 1585 |
|
|
2016
Q4 | $543K | Buy |
6,399
+23
| +0.4% | +$1.81K | ﹤0.01% | 1769 |
|
|
2016
Q3 | $475K | Sell |
6,376
-1,517
| -19% | -$120K | ﹤0.01% | 1587 |
|
|
2016
Q2 | $599K | Sell |
7,893
-1,035
| -12% | -$75.3K | ﹤0.01% | 1508 |
|
|
2016
Q1 | $619K | Sell |
8,928
-882
| -9% | -$53.1K | ﹤0.01% | 1480 |
|
|
2015
Q4 | $590K | Buy |
9,810
+93
| +1% | +$5.59K | ﹤0.01% | 1634 |
|
|
2015
Q3 | $525K | Buy |
9,717
+2,126
| +28% | +$124K | ﹤0.01% | 1385 |
|
|
2015
Q2 | $442K | Buy |
7,591
+220
| +3% | +$12.3K | ﹤0.01% | 1465 |
|
|
2015
Q1 | $444K | Buy |
7,371
+2,616
| +55% | +$139K | ﹤0.01% | 1595 |
|
|
2014
Q4 | $254K | Sell |
4,755
-98
| -2% | -$4.9K | ﹤0.01% | 1642 |
|
|
2014
Q3 | $217K | Buy |
+4,853
| New | +$206K | ﹤0.01% | 1647 |
|
Other funds holding WST
VCM
VPM
GIM
HSBC Holdings's WST Position: Q1 2026 in Review
HSBC Holdings increased its West Pharmaceutical (WST) stake by 6.8% in Q1 2026, buying an estimated $2.49M and bringing the position to 156,895 shares worth $39.3M. The position accounts for 0.02% of the portfolio, ranked #571.
HSBC Holdings first reported a position in WST in Q3 2014 and has held it in 47 quarters since. The position peaked at $66.1M in Q1 2024. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- HSBC Holdings held 156,895 shares of West Pharmaceutical worth $39.3M as of Q1 2026.
- HSBC Holdings bought 10,023 West Pharmaceutical shares in Q1 2026, an estimated $2.49M.
- West Pharmaceutical made up 0.02% of HSBC Holdings's portfolio in Q1 2026, its #571 holding.
- HSBC Holdings first reported a position in West Pharmaceutical in Q3 2014 and has held it in 47 quarters since.
- HSBC Holdings's West Pharmaceutical position peaked at $66.1M in Q1 2024.
- 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.